Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 100
Avg Vol 1,956
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 47%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with cond...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9389 1911
Fax: 61 3 9389 1434
Website: www.csl.com
Address:
655 Elizabeth Street, Melbourne, Australia
Latest News on CMXHF
No data available.